← All organizations

Keocyt

For profit

Also known as: Keocyt

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Aug 10, 2017

Acquired by RIEMSER Arzneimittel GmbH → Esteve Labs on May 12, 2014

Timeline

2000s

Jun 1, 2006
Keocyt— Founded

2010s

May 12, 2014
RIEMSER Arzneimittel GmbH— Acquired By

2020s

Jan 8, 2020
Esteve Labs— Now

Drugs by trial phase (1 distinct, 1 trials)

Phase 2 (1 own, 0 via acquisition)

allogeneic hematopoietic stem cells

Indications

Studied for

Anemia, Sickle Cell

Recent trials (1)

NCT03240731CollaboratorPhase 2Aug 10, 2017

Details

Founded: Malakoff, FR Jun 1, 2006
Last known activity: Aug 10, 2017